Universidad Juárez Autónoma de Tabasco
🇲🇽Mexico
Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 4
1 (50.0%)T1D, Metabolic Syndrome and Insulin Resistance
Completed
- Conditions
- Type 1 DiabetesInsulin ResistanceMetabolic Syndrome
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- Universidad Juárez Autónoma de Tabasco
- Target Recruit Count
- 19
- Registration Number
- NCT05503303
- Locations
- 🇲🇽
Isela Esther Juarez Rojop, Villahermosa, Tabasco, Mexico
Detection of LADA in a Hospital in the Mexican Southeast
Completed
- Conditions
- Latent Autoimmune Diabetes
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Universidad Juárez Autónoma de Tabasco
- Target Recruit Count
- 110
- Registration Number
- NCT05235672
- Locations
- 🇲🇽
Isela Esther Juarez Rojop, Villahermosa, Tabasco, Mexico
Vortioxetine vs Sertraline in Mexicans
Phase 4
Completed
- Conditions
- Type 2 Diabetes MellitusDepression
- Interventions
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2019-06-13
- Lead Sponsor
- Universidad Juárez Autónoma de Tabasco
- Target Recruit Count
- 21
- Registration Number
- NCT03978286
Effect of Food Consumption on microRNA Related to Metabolic Syndrome
Not Applicable
- Conditions
- Metabolic Syndrome X
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Universidad Juárez Autónoma de Tabasco
- Target Recruit Count
- 50
- Registration Number
- NCT02606812
News
No news found